Literature DB >> 6799075

Family study of antipyrine clearance.

P G Blain, J C Mucklow, P Wood, D F Roberts, M D Rawlins.   

Abstract

Antipyrine clearance was measured in 208 healthy volunteers from 78 families. After the values had been corrected for weight and sex, antipyrine clearance was observed to be significantly correlated between siblings (r = 0.590) and between spouses (r = 0.320), but not between parents and their offspring. After the clearance values had been corrected for tobacco and oral contraceptive use, there was still no significant correlation between parents and offspring. These results are incompatible with the hypothesis that antipyrine clearance is primarily determined by genetic factors and indicate that environmental influences predominate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6799075      PMCID: PMC1495529          DOI: 10.1136/bmj.284.6310.150

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  17 in total

1.  Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.

Authors:  R E Vestal; A H Norris; J D Tobin; B H Cohen; N W Shock; R Andres
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Assessment of antipyrine kinetics by measurement in saliva.

Authors:  H S Fraser; J C Mucklow; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

3.  Impairment of human drug metabolism by oral contraceptive steroids.

Authors:  K O'Malley; I H Stevenson; J Crooks
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

4.  Genetic control of drug levels in man: antipyrine.

Authors:  E S Vesell; J G Page
Journal:  Science       Date:  1968-07-05       Impact factor: 47.728

5.  Effect of environmental factors on drug metabolism: decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides.

Authors:  B Kolmodin; D L Azarnoff; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1969 Sep-Oct       Impact factor: 6.875

6.  Genetic control of phenylbutazone metabolism in man.

Authors:  J A Whittaker; D A Evans
Journal:  Br Med J       Date:  1970-11-07

7.  Alterations in drug metabolism in workers exposed to polychlorinated biphenyls.

Authors:  A P Alvares; A Fischbein; K E Anderson; A Kappas
Journal:  Clin Pharmacol Ther       Date:  1977-08       Impact factor: 6.875

8.  Enhanced drug metabolism in cigarette smokers.

Authors:  P Hart; G C Farrell; W G Cooksley; L W Powell
Journal:  Br Med J       Date:  1976-07-17

9.  Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.

Authors:  A Kappas; K E Anderson; A H Conney; A P Alvares
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

10.  Effect of age and sex on human drug metabolism.

Authors:  K O'Malley; J Crooks; E Duke; I H Stevenson
Journal:  Br Med J       Date:  1971-09-11
View more
  9 in total

1.  Interindividual variations in drug disposition. Clinical implications and methods of investigation.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

Review 2.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

3.  Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.

Authors:  M B Penno; E S Vesell
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

4.  Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health.

Authors:  P G Blain; J C Mucklow; M D Rawlins; D F Roberts; P A Routledge; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

Review 5.  Genetic predisposition to lung cancer.

Authors:  M R Law
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

6.  Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.

Authors:  M Eichelbaum; T Tomson; G Tybring; L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

7.  Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.

Authors:  M Eichelbaum; L Bertilsson; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

Review 8.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

9.  2-Phenyl-8,9,10,11-tetra-hydro-1-benzo-thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine.

Authors:  Shridhar I Panchamukhi; Nikhath Fathima; I M Khazi; Noor Shahina Begum
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.